Q4 EPS Forecast for Intuitive Surgical Lowered by Analyst

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Analysts at Leerink Partnrs cut their Q4 2024 earnings per share estimates for shares of Intuitive Surgical in a research note issued on Monday, November 25th. Leerink Partnrs analyst M. Kratky now anticipates that the medical equipment provider will earn $1.34 per share for the quarter, down from their previous estimate of $1.36. The consensus estimate for Intuitive Surgical’s current full-year earnings is $5.45 per share. Leerink Partnrs also issued estimates for Intuitive Surgical’s FY2025 earnings at $6.02 EPS.

A number of other brokerages also recently weighed in on ISRG. Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James lifted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, Truist Financial raised their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $538.55 on Tuesday. Intuitive Surgical has a 1 year low of $304.50 and a 1 year high of $552.00. The firm has a market cap of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39. The company has a 50-day moving average of $507.94 and a 200 day moving average of $466.79.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors have recently made changes to their positions in ISRG. Ridgewood Investments LLC bought a new position in Intuitive Surgical in the second quarter worth approximately $26,000. Godsey & Gibb Inc. raised its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. Creekmur Asset Management LLC lifted its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC lifted its position in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter worth about $33,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,459 shares of company stock valued at $26,080,251. Company insiders own 0.80% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.